首页    期刊浏览 2024年11月25日 星期一
登录注册

文章基本信息

  • 标题:Have thyroid hormones an impact on ovarian cancer?
  • 本地全文:下载
  • 作者:Klaudia Żak ; Sylwiusz Niedobylski ; Milena Leziak
  • 期刊名称:Journal of Education, Health and Sport
  • 电子版ISSN:2391-8306
  • 出版年度:2018
  • 卷号:8
  • 期号:12
  • 页码:803-809
  • DOI:10.5281/zenodo.2537850
  • 语种:English
  • 出版社:Kazimierz Wielki University
  • 摘要:Thyroid hormones show not only genomic, but also nongenomic activity, which is related to specific membrane, cytoplasmic and organelle receptors. The best known receptors are located on the alpha-V-beta-3 integrin of cell membrane. Their stimulation results in an activation of mitogen-activated protein kinases (MAPKs) or phosphoinositide 3-kinase (PI3K), which directly leads to an inhibition of apoptosis and increased proliferation of tumor cells, as well as promotes angiogenesis and metastasis formation. In ovarian cancer cells L-thyroxine is proven to be involved in MAPK activation as well as in the up-regulation of expression and enhanced cellular accumulation of programmed death ligand 1 (PD-L1), which results in an inhibition of neoplastic cells apoptosis.
  • 关键词:Thyroid hormones show not only genomic, but also nongenomic activity, which is related to specific membrane, cytoplasmic and organelle receptors. The best known receptors are located on the alpha-V-beta-3 integrin of cell membrane. Their stimulation results in an activation of mitogen-activated protein kinases (MAPKs) or phosphoinositide 3-kinase (PI3K), which directly leads to an inhibition of apoptosis and increased proliferation of tumor cells, as well as promotes angiogenesis and metastasis formation. In ovarian cancer cells L-thyroxine is proven to be involved in MAPK activation as well as in the up-regulation of expression and enhanced cellular accumulation of programmed death ligand 1 (PD-L1), which results in an inhibition of neoplastic cells apoptosis.
国家哲学社会科学文献中心版权所有